Off-label use of tocilizumab in patients with SARS-CoV-2 infection.

Simona Di GiambenedettoArturo CicculloAlberto BorghettiGiovanni GambassiFrancesco LandiElena ViscontiLorenzo Zileri Dal VermeRoberto BernabeiEnrica TamburriniRoberto CaudaAntonio Gasbarrini

Published in: Journal of medical virology (2020)

Keyphrases

rheumatoid arthritis
juvenile idiopathic arthritis
respiratory syndrome coronavirus
rheumatoid arthritis patients
disease activity
sars cov
systemic lupus erythematosus